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Abstract
Background: Myostatin (MSTN) encodes a negative regulator of skeletal muscle mass that might have applications
for promoting muscle growth in livestock. In this study, we aimed to test whether targeted MSTN editing, mediated
by transcription activator-like effector nucleases (TALENs), is a viable approach to create myostatin-modified goats
(Capra hircus).
Results: We obtained a pair of TALENs (MTAL-2) that could recognize and cut the targeted MSTN site in the goat
genome. Fibroblasts from pedigreed goats were co-transfected with MTAL-2, and 272 monoclonal cell strains were
confirmed to have mono- or bi-allelic mutations in MSTN. Ten cell strains with different genotypes were used as
donor cells for somatic cell nuclear transfer, which produced three cloned kids (K179/MSTN−/−, K52-2/MSTN+/−,
and K52-1/MSTN+/+).
Conclusions: The results suggested that the MTAL-2 could disrupt MSTN efficiently in the goat genome.
The mutated somatic cells could be used to produce MSTN-site mutated goats without developmental disruption.
Thus, TALENs is an effective method for accurate genome editing to produce site-modified goats.
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Background
Myostatin (encoded by the MSTN gene) is a member of
the transforming growth factor family that acts as an
important negative regulator of skeletal muscle growth
[1, 2]. Mutations in MSTN can inactivate its expression
and result in a nonfunctional protein, which has great
potential to enhance muscle growth, leading to dramatic
muscularity and a “double-muscling” phenomenon in
many species, including cattle [3], mice [4], humans [5],
and sheep [6]. Recent studies showed that inhibiting
MSTN increases skeletal muscle mass, reduces fat mass,
and inhibits diet-induced and genetic obesity [7–9], pro-
viding an opportunity to improve the production of
meat in livestock. Several research institutions have
attempted to produce MSTN knockout goats or sheep
[9–13]. However, because of the low rate of conventional
homologous recombination or zinc-finger nuclease (ZFN)-
mediated knockout, there have been few reports of success-
fulMSTN knockout goats [13].
Recently, the newly developed transcription activator-like
effector nucleases (TALENs) and clustered regularly inter-
spaced short palindromic repeats (CRISPR) techniques
have emerged as powerful genetic tools to edit the genome
precisely [14–17]. They represent a promising approach for
targeted knockout at specific genomic loci, and have been
used widely to perform precise genome editing in a wide
range of organisms [15, 18–20]. Recent advances in the
study of the CRISPR system have resulted in improved
efficiency that allowed it to rapidly replace other genome
editing platforms, including ZFNs and TALENs. Outstand-
ing work has been done by one team of researchers using
CRISPR/Cas9 to edit the goat genome. In that work, they
produced MSTN mutated founders. These founders should
be valuable for research into MSTN. At same time, some
off-target modifications were detected in their founders
[11]. However, as new breeds of goat for human consum-
ption, we must avoid or reduce the risk of off-target
mutations as much as possible. Some reports showed that
no or few off-target mutations were detected in the animals
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created by TALENs [14, 21, 22]. The latest report also
showed that the cloned cattle created by TALENs com-
bined with SCNT are free of off-target events [23]. Thus, to
reduce or avoid the induction of off-target mutations, we
chose the TALEN approach for MSTN editing in goats. As
far as we know, MSTN-knockout in goats using TALENs
has not been reported.
In this paper, we tested whether direct MSTN-editing
mediated by TALEN in goat cells is a viable approach to
produce MSTN mutant goats. To accomplish this, we
considered two objectives: (i) to design functional MSTN-
modified TALENs; and (ii) to develop methods for
TALEN-mediatedMSTN modification in a cloned goat.
Results
Evaluation of TALENs efficiency
We designed and assembled four pair of TALENs
(Additional file 1: Table S1) each to target the first exon,
first intron and third exon of goat MSTN. Each TALEN
pair was transfected into primary GFFCs (goat fetus fibro-
blast cells), and PCR was used to measure the efficiency of
genome modification was measured at 72 h after transfec-
tion. Sequencing and restriction analyses of the amplicons
revealed that one pair of TALENs (MTAL-2, targeting the
first exon) resulted in detectable gene-editing activity. A
schematic and the binding sequences of MTAL-2 are
shown in Fig. 1a. Restriction analysis showed that the
restriction enzyme could not completely cut the PCR
amplicon from the mixed cells, when co-transfected with
MTAL-2 expression plasmids (Fig. 1b). The sequencing
ideograms of the cells transfected with MTAL-2 showed
multiple peaks after the targeting site (Fig. 1c). The TA-
cloning sequencing showed 7 of 36 TA-cloning were
detected with mutation. The frequency of mutated alleles
was estimated at about 19.4 %.
Generation of MSTN-modified goat fetal fibroblasts
Eleven days after transfection with MATL-2, 320 mono-
clonal cell strains were randomly isolated. An AluI re-
striction site was designed in the MTAL-2 cut site.
Genotyping was performed by PCR amplification, AluI
digestion, and TA-cloning sequencing. Additional bands
were observed by PCR amplification of the target region
in some of the cell strains (Fig. 2a), indicating that gen-
omic modification had occurred in these cells. As shown
in Fig. 2a, when the PCR products were digested with
AluI, two bands were observed in wild-type cell strains,
and a 444-bp additional band was observed in mono-
Fig. 1 Design of the TALENs assay targeting the goat MSTN locus. a Schematic showing the DNA-binding sites and spacer sequence of MTAL-2
in MSTN exon 1. b Modification of MSTN in GFFCs when transfected with one pair of functional TALENs (MTAL-2). Surveyor nuclease cleavage of
the unsorted cells’ PCR products produced an expected 444-bp band, while WT cells produced a 289-bp band and a 145-bp band. ‘- -’ means no
additional band was observed; ‘+ +’ means the additional band was observed. c Mutation identified in mixed transfection cells. DNA fragments
surrounding the TALEN target sites were analyzed by direct DNA sequencing. The sequencing ideogram shows a series of peaks after the
targeting site
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allelically modified cell strains, while only one 444-bp
band was observed in bi-allelically modified cell strains.
The results indicated that 272 (85 %) cell strains were
modified at the MSTN locus. Among these cells strains,
174 (64 %) were mono-allelically modified and 98 (36 %)
were bi-allelically modified (Table 1). TA-cloning sequen-
cing of all bi-allelically modified cell strains and 34 well-
grown, mono-allelically modified cell strains showed that
MTAL-2 induced small insertions or deletions in the tar-
get site, as shown in Fig. 2b. Three cell strains were identi-
fied as having homozygous mutations (Fig. 2b).
Generation of MSTN mutant fetuses and goats
To produce MSTN mutant goats, 10 well-grown cell
strains with different sexes and genotypes were selected
for use as donor cells for somatic cell nuclear transfer
(SCNT). As shown in Fig. 2b, three cell strains were
mono-allelically modified, four were bi-allelically modified,
and three were homozygously modified. Four hundred
and three embryos were reconstructed and transferred
into 29 synchronized recipients. Seven (24 %) recipients
were confirmed as pregnant by transrectal ultrasonog-
raphy 30 days after embryo transfer. Three fetuses were
obtained from three pregnant recipients derived from
donor cells of different genotypes (Fig. 2b). The fetal cell
lines (named C231-1, C231-2 and C323) were isolated and
expanded for use in recloning. Sequence analyses showed
the all the fetuses had the same genotype as their donor
cells. C231-1 and C231-2, derived from L231, had the
same genotype and were modified biallelically. C323,
derived from L323, was modified homozygously (Fig. 2b
and c). The results suggested that TALEN-mediated
MSTN-modified cells could support early embryonic
development, and the mutations could be stably inherited.
Two pregnant recipients carried their kids to term,
delivering three female kids (named K179, K52-1, and
K52-2; weighing 5.8 kg, 3.4 kg, and 4.5 kg, respectively)
(Fig. 3a–c). However, K179 died because of a difficult
labor and produced edema, K52-1 died 1 h after cesarean
section, and K52-2 is currently alive and healthy (Fig. 3f).
Restriction enzyme digestion showed K179 (derived from
L179) was bi-allelically modified, and K52-2 (derived from
L52) was mono-allelically modified, while K52-1 had no
mutation (Fig. 3g). The results suggested that MSTN-
modified cells produced by TALENs could support em-
bryonic development, resulting in MSTN-modified goats.
Fig. 2 Sequence analysis of the MSTN locus in transfected cell strains. a Surveyor nuclease cleavage of the transfected cell strains. The amplicons from
21 cell strains were digested by restriction enzyme Alu I. Two bands were observed in wild-type cell strains, as shown in lanes 12, 14, and 15. Three
bands were observed in mono-allelically modified cell strains or mixture cells, containing a 444-bp additional band, as shown in lanes 1–3, 5, 8, 9, 11,
and 19–21. Only one 444-bp band was observed in bi-allelically modified cell strains, as shown in lanes 4, 6, 7, 10, 13, and 16–18. b Sequence variations
at the cleavage site of 10 donor cell strains were aligned with the wild-type sequence. L52, L383, and L385 had mono-allelic mutations; L95, L170,
L179, and L231 had bi-allelic mutations; and L193, L301, and L323 had homozygous mutations. ‘-’ means frameshift mutant; ‘+’ means insertion mutant.
c Sequence analysis of the cloned fetuses. Three cloned fetuses (named C231-1, C231-2, and C323) were obtained from two recipients. C231-1 and
C231-2, containing the same genotype, came from the bi-allelic mutant donor cell L231. C323 came from the homozygous mutant donor cell L323




Count Percentage (%) Homozygous
mutations
Total 320
Mono-allelic mutant 174 54.4 -
Bi-allelic mutant 98 30.6 3 (1 %)
Wild type 48 15 -
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Characterization of cloned goats
Sequence analyses of the cloned kids showed that a 1-bp
insertion and a 13-bp deletion were present in the target
site of the K179 kid (Fig. 3i and j), and a 3-bp deletion was
detected in one allele of the K52-2 kid (Fig. 3k). The muta-
tions in K179 were predicted to result in a null mutation
because they occurred after the first 68 and 65 amino
acids of the C-terminal region, respectively, resulting in
the loss of 307 and 310 amino acids (Fig. 3l). The muta-
tion in K52-2 resulted in a proline loss in the mature
region of the protein (amino acid 70, Fig. 3l). Western blot
analysis further demonstrated that myostatin was not
expressed in K179 and K52-2 showed lower myostatin
expression than K52-1 (Fig. 4a).
MSTN mutations in goats might lead to increased mus-
cularity. Compared with the wild-type cloned kid K52-1/
MSTN+/+, K179/MSTN−/− showed a dramatic and wide-
spread increase in skeletal muscle (Fig. 3d and e). The
body weight of K179/MSTN−/− was 1.7 times higher than
K52-1/MSTN+/+, although this result could not be accur-
ately estimated because of edema. Compared with the
wild-type littermate K52-1/MSTN+/+, the body weight of
K52-2/MSTN+/− was increased by 32 % weight and the
mean fiber area increased by 8.8 % (P < 0.05, Fig. 4b and
c). Furthermore, K52-2/MSTN+/− showed the same
frequency distribution of myofibers (Fig. 4d) as was dem-
onstrated in MSTN-knockout mice [24]. These results
suggested that we generated a novel method to block
MSTN expression in goats, which has potential to improve
goat meat production.
Off-target analysis
To assay the specificity of MTAL-2 induced DNA disrup-
tion, we employed the protocol described by Yong L et al.
[25] to scan the genomic sequences in goats. The spacers
between the two effector-binding elements in all the
potential off-target cleavage sites were greater than 100-
bp, which were too long to form Fok I dimerization. Thus,
the PCR test that was performed in previous studies to
confirm off-target sites was unnecessary [25–28]. In
addition, the six most potential off-target cleavage sites
were predicted (Additional file 2: Table S3) and analyzed
Fig. 3 Phenotype and genotype analysis of cloned goats. a–c Photographs of the cloned goats at the first day after birth. d, e Phenotypes of
K179/MSTN−/− and K52-1/MSTN+/+. The leg portion of the carcass. Pictures of the femoris muscles of skinned cloned goats are shown. f Picture of
the live goat K52-2 at 4 months. g Mutation confirmation in the cloned goats. h–k Sequence analysis of the cloned goats. l Amino acid sequence
analysis of the cloned goats
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by DNA sequencing. No evidence of off-target cleavage
events could be identified. The information on the off-
target loci and primer pairs used are listed in additional files
(Additional file 2: Table S3 and Additional file 3: Table S4).
Discussion
In this study, one pair of functional TALENs was identi-
fied and was used to generate bi- or mono-allelic mutant
cells, which were used as donor cells for SCNT, resulting
in bi- and mono-allelic-modified goats. These results
showed that the combination TALEN-mediated genome
editing with SCNT is a useful method to accomplish
MSTN mutagenesis in goats.
In recent years, developments in ZFNs, TALENs, and
CRISPR technologies have emerged as alternatives to clas-
sical breeding and transgenic methods to improve live-
stock. When deciding which technology to use in an
experiment, it is very important to consider the final appli-
cation of the mutated animals [17]. In this research, we
attempted to create new breeds of goat to improve muscle
yield, with the ultimate goal of approval for human con-
sumption. To avoid or prevent significant risks of off-
target mutations, we chose TALENs to achieve mutagen-
esis instead of CRISPR. Even though CRISPR has emerged
recently as a potentially facile and efficient alternative to
ZFNs and TALENs to induce targeted genetic alterations,
CRISPR does not have better specificity than TALENs or
ZFNs [17, 26]. Meanwhile previous studies have shown
that low efficacy and minor off-target mutations may exist
in TALEN-induced animals [22, 23, 28–31]. However,
TALENs still provides a valuable option, thanks to its rela-
tively high specificity [26]. Off-target analysis of the cloned
goats revealed that no off-target sequences were detected.
Additional studies will be required to evaluate the specifi-
city of our functional TALENs.
Natural mutations in MSTN first exon [32], first intron
[33], second exon [32], and third exon [34] have been
found in animal populations, and all these mutations can
lead to the double-muscle phenotype. Existing research
shows that nucleotide variation among introns results in
differential degrees of gene expression in eukaryotic cells
[35]. In the present study, we tried to induce similar muta-
tions in goat MSTN locus to knockout or reduce the ex-
pression of MSTN. The results indicated that MTAL-2,
targeting for the first exon, could modify the MSTN locus.
Most mutations induced by MTAL-2 were frameshifts in
the target site, and the same mutation could be found at a
high frequency in different cell strains. Cloned goats, de-
rived from mutant cells with different sexes but containing
the same mutation, can be used to produce homozygous
mutant offspring by mating. In addition, the homozygous
mutant cells can be used directly as donor cells for SCNT
to produce homozygous animals.
SCNT is an important technology that has been used to
clone certain livestock species [36]. Microinjection com-
bined with TALEN mRNA is an efficient method that has
been used to target MSTN in mice [37]. However, some
reports stated that many of the resulting founder animals
Fig. 4 Myofibers and western blot analysis of MSTN-targeted goats. a Myostatin protein expression of K179, K52-1, and K52-2 was normalized to
β-actin expression using western blot assays. b Muscle cross-sections of K52-2/MSTN+/− and K52-1/MSTN+/+. Tissue sections were prepared from
the fore limb tricep muscles that was dissected from the cloned goat 2 h after birth. c, d Mean average area and frequency distribution of the
myofibers in a given cross-sectional area. In the K52-2/MSTN+/− and K52-1/MSTN+/+ groups, 338–374 randomly selected myofibers was measured
and used for analysis. *P value less than 0.05 considered as statistically significant. d The blue shaded area shows that more myofibers are in the
1000–3999 μm2 range in K52-1/MSTN+/+; the red shaded area shows that more myofibers are in the 4000–6999 μm2 range in K52-2/MSTN+/−
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were chimeric, with multiple mutations [22, 27, 37]. The
injection of TALENs into embryos is not as feasible in
large animals as in small animals because large animals
have longer gestation cycles and high recipient costs,
which make it difficult to achieve large animal offspring
with a single expected mutation [28]. The major advan-
tage of SCNT over direct embryo injection with editor
reagents is the predictable genotype of the offspring and
the ability to generate clonal lines of edited animals [18].
Therefore, in this study, we chose expected genotype som-
atic cells modified by TALENs followed by SCNT to pro-
duceMSTN edited goats.
Three cloned goats derived from cells with the same
genetic background were created. The MSTN-modified
goats shared several hypermuscular features with MSTN-
modified mice [37] or cattle. Our results showed that loss
of myostatin did not disturb embryonic development, but
led to increased body weight and mean fiber area.
Conclusions
TALENs construct MATL-2 provided efficient MSTN
gene disruption in the goat genome. The MSTN-modi-
fied cells could be used as donor cells for SCNT to
produce MSTN-site mutated goats without disruption of
embryonic development. Loss of myostatin protein re-
sulted in muscular hypertrophy. These results represent
an effective way to produce “double muscle” goat breeds.
Methods
Design and assembly of TALEN expression plasmids
The first exon, third exon, and its immediate flanking re-
gions of the Capra hircus MSTN gene (NG_EF588034.1)
were scanned for putative TALEN-binding pairs using
TAL Effector Nucleotide Targeter 2.0 [38]. Four pairs of
TALEN-binding pairs were chosen to construct TALEN
expression plasmids using the FastTALETM TALEN
Assembly Kit (Shanghai, China; Cat. No. 1802-030). The
TALEN expression backbone contains a CMV promoter
for expression in mammalian cells and a puromycin
selection cassette for transient enrichment of transfected
cells expressing TALENs.
Animals
Yangtze River Delta white goats and Boer goats were kept
in the Research Farm of Yangzhou University, China. All
surgical procedures were performed in accordance with
the Guiding Principles for the Care and Use of Laboratory
Animals and were approved by the Institutional Animal
Care and Use Committee of Yangzhou University.
TALEN evaluation and edited cells
Goat fetal fibroblasts isolation and culture methods were
the same as those described in a previous study [39]. 2 ×
106 cells were electroporated (Eppendorf multiporator)
with 4 μg of the right-arm-TALEN encoding plasmid
and 4 μg of the left-arm-TALEN encoding plasmid,
under the following conditions: 400 V for 300 μs with
one pulse. Empty backbone plasmid was used as a
control. Puromycin (3 μg/mL) was added 24 h after
transfection. Cells were collected at 72 hs after transfec-
tion. The targeted regions were PCR amplified (Primer
sequences were shown in Additional file 4: Table S2)
from genomic DNA and the amplicons were sequenced.
To obtain mutant cell strains, the functional TALEN
expression plasmids were co-transfected into male or fe-
male goat fetal fibroblasts. Puromycin-resistant cells were
cultured for another 7 days in normal medium, after which
monoclonal cells could be observed. A cloning cylinder
(C1059, Sigma) was then loaded around the single cell
colony, and the cells were digested with trypsin. The mono-
clonal cell strains were then subcultured on 48-well culture
plates. A portion of the cell culture was collected for cryo-
preservation, and the remaining cells were used for PCR
screening to confirm the presence of the mutation. The
PCR products were analyzed by restriction analysis and se-
quencing, before and after cloning into TA vectors.
Nuclear transfer
The methods of animal treatment, oocyte collection, nu-
clear transfer, embryo transfer, and pregnancy status were
as described in previous studies [39, 40]. Ten cell strains
of different sexes were used as donor cells for SCNT. Sev-
eral cell lines containing a desired mutant genotype were
isolated from pregnant recipients and expanded to be used
as donor cells for the next round of SCNT.
Characterization of cloned kids
The cloned goats were weighed after birth, and their gen-
omic DNA was extracted from the umbilical cord. To
confirm the mutation, the PCR products of the cloned
goats were analyzed by restriction analysis and sequencing
before and after cloning into TA vectors. To observe the
phenotype of the cloned goats, the dead goats were dis-
sected and observed. The tricep muscles from the fore
limbs in the cloned goats were isolated by a minimally in-
vasive surgery at birth. Muscles were collected from dead
goats and isolated from surviving goats by a minimal inva-
sive procedure to make tissue sections and to extract pro-
teins. The myofibers were subjected to straining and
measured using the method reported in a previous study
[24]. Muscle sections were photographed at 400× magnifi-
cation. The muscle cross-sectional area was calculated
using ImageJ software (National Institutes of Health, New
York, USA). Data for myo-fibers were analyzed by a gen-
eral linear model of regression using SPSS (General Linear
Model, SPSS 11.0; SPSS, Inc., USA). Western blot analysis
was conducted using a standard protocol. Antibodies for
myostatin (Cat. No. ab98337), β-actin (Cat. No. ab8229),
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and goat polyclonal secondary antibody for rabbit IgG (Cat.
No. ab97080) were purchased from the AbCam Company
(AbCam, Inc., Cambridge, MA, USA).
Off-target assay
To verify whether off-target mutations occurred in cloned
goats, the target sequence of the active TALENs was searched
in web software (http://blast.ncbi.nlm.nih.gov/Blast.cgi). The
potential off-target sites were evaluated by sequencing.
Additional files
Additional file 1: Table S1. TALEN target sequences. (DOC 35 kb)
Additional file 2: Table S3. Off-target sites assayed for MTAL-2.
(DOC 83 kb)
Additional file 3: Table S4. Primer pairs for PCR amplification of
off-target regions for MTAL-2. (DOC 32 kb)
Additional file 4: Table S2. Primers for PCR amplification of TALENs
target regions. (DOC 29 kb)
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